DOW JONES28,014.88+54.08 0.19%
S&P 5003,229.90+4.01 0.12%
NASDAQ9,184.06-37.22 -0.40%

H.C. Wainwright Initiates Coverage On Enlivex Therapeutics with Buy Rating, Announces $20 Price Target

H.C. Wainwright analyst Raghuram Selvaraju initiates coverage on Enlivex Therapeutics (NASDAQ:ENLV) with a Buy rating and a $20 price target.

Benzinga · 01/09/2020 14:04

H.C. Wainwright analyst Raghuram Selvaraju initiates coverage on Enlivex Therapeutics (NASDAQ:ENLV) with a Buy rating and a $20 price target.